NIH-funded research P01 program project

How cells repair stuck DNA-copying machinery

Official title: Project 4: Fork Repair: Mechanisms and consequences of stalled replication fork processing

Funded at University of Calif-Lawrenc Berkeley Lab · NIH-11178316 · Data updated 2026-11-12

Researchers are learning how cells fix or bypass stalled DNA replication to better understand cancer and improve treatments.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Calif-Lawrenc Berkeley Lab
NIH-funded
Lab location1 site (Berkeley, United States)
Project startSeptember 27, 2001
Project endAugust 31, 2026
Funding year2025
Award (this year)$380,882
NIH project number5P01CA092584-25
Project IDNIH-11178316 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancers linked to DNA repair defects (for example BRCA-mutant tumors or cancers treated with PARP inhibitors) are most likely to find this research relevant.

Less likely to help

Patients whose cancers are unrelated to DNA replication or repair pathways may not directly benefit from these findings.

What this research studies

This project uses laboratory experiments to find out how cells deal with stalled DNA replication forks, a process that can create the mutations that drive cancer. Scientists combine structural studies, biochemistry, genetics, and cell biology to identify the proteins and pathways that remodel, repair, or bypass these stalled forks. They also study how error-prone fixes lead to genetic changes and therapy resistance. The goal is to reveal vulnerabilities that could be targeted by future cancer therapies.

Why it matters

Potential benefit: If successful, this work could point to new ways to make cancer treatments more effective by targeting how tumor cells tolerate DNA replication stress.

How similar studies have gone: Prior basic-science work on replication and repair has informed treatments like PARP inhibitors, but many specific mechanisms of fork processing remain novel and underexplored.

Where this research is happening

  • University of Calif-Lawrenc Berkeley Lab
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Cortez, David K — University of Calif-Lawrenc Berkeley Lab
  • Study coordinator: Cortez, David K

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.